SUBSCRIBE
SUBSCRIBE
News   Business

Progen Pharmaceuticals Limited Launches PharmaSynth Manufacturing Unit

July 8, 2008 | 
1 min read

Biotechnology firm ProGen Pharmaceuticals has spun-out its manufacturing operations as the new wholly-owned subsidiary PharmaSynth.

Startups Asia Australia
MORE ON THIS TOPIC
Find understanding between people. Reach your opponent. Building a bridge of understanding and reasoning. Discover common ground. Pave way for cooperation or peaceful disagreement. Resolving conflict
Mergers & acquisitions
Bluebird’s Second Suitor, Ayrmid, Fails To Produce an Offer
April 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Art 3d banner collage of business people dollar roll cooperation success payment capital profit transaction money corruption.
Rare diseases
Glycomine Gets $115M Series C for Rare Disease, Aims for Phase II Launch Mid-Year
April 16, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Podcast
Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed
April 16, 2025
 · 
1 min read
 · 
Heather McKenzie
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives
April 15, 2025
 · 
179 min read
 · 
BioSpace Editorial Staff